ASML Holding N.V. — 2017 Form 20-F Summary
Reporting period: Fiscal year ended December 31, 2017. This is an annual report, not a standalone fourth-quarter filing; the supplied text does not provide a clear set of Q4-only financial results. Financial statements are prepared under U.S. GAAP and reported in euros.
Business context
ASML develops, manufactures, sells and services semiconductor lithography equipment and related metrology and inspection products. Its main offerings are deep ultraviolet (DUV), extreme ultraviolet (EUV) and Holistic Lithography solutions. Management described 2017 as a record year and a breakthrough year for EUV, with technology progress supporting customers’ transition to advanced chip manufacturing.
Financial performance and liquidity
| Metric | 2017 | 2016 | Change or context |
|---|---|---|---|
| Total net sales | €9,052.8 million | €6,794.8 million | Up 33.2% |
| Net system sales | €6,373.7 million | €4,672.0 million | Up 36.4% |
| Net service and field option sales | €2,679.1 million | €2,122.8 million | Up 26.2% |
| Gross profit / gross margin | €4,076.7 million / 45.0% | €3,044.5 million / 44.8% | Margin improved 0.2 percentage points |
| Income from operations / operating margin | €2,496.2 million / 27.6% | €1,657.7 million / 24.4% | Operating margin improved 3.2 percentage points |
| Net income / net margin | €2,118.5 million / 23.4% | €1,471.9 million / 21.7% | Basic EPS €4.93, versus €3.46 |
| Operating cash flow | €1,798.6 million | €1,665.9 million | Up from prior year |
| Free cash flow | €1,440.6 million | €1,341.2 million | Non-GAAP measure |
| Cash and cash equivalents | €2,259.0 million | €2,906.9 million | Down year over year |
| Short-term investments | €1,029.3 million | €1,150.0 million | Down year over year |
| Total debt carrying amount | €3,025.3 million | €3,319.5 million | Includes current portion |
Year-end working capital was €5,665.1 million. ASML also had an undrawn €700 million revolving credit facility, extended to mature in 2022. The company reported that cash generated from operations and other liquidity sources were sufficient for expected requirements, including capital expenditures and debt service.
Material changes and notable developments
- System sales growth reflected 11 EUV systems recognized in sales, versus 4 in 2016; 187 DUV systems recognized, versus 153; and a full year of HMI sales in 2017, compared with two months in 2016. ASML separately reported shipping 10 NXE:3400B EUV systems to customers in 2017.
- Service and field option sales benefited from a larger installed base and higher sales of productivity and focus upgrades.
- Gross margin rose slightly as the system mix shifted toward higher-end products, partly offset by higher EUV sales. Management said the EUV business did not achieve a 0% gross margin for 2017, partly due to accelerated investment in EUV service infrastructure.
- R&D expense increased 13.9% to €1,259.7 million, or about 14% of sales, with emphasis on EUV, DUV immersion and Holistic Lithography.
- ASML acquired a 24.9% indirect interest in Carl Zeiss SMT Holding for €1.0 billion. It recorded a €16.7 million loss from equity method investments, including acquisition-related basis-difference effects.
- Cash declined amid investment activity and shareholder returns. Investing cash flows included €1,019.7 million for the Carl Zeiss equity investment; financing cash flows included €516.7 million in dividends, €500 million in share repurchases and €243.0 million in debt repayments.
Outlook, risks and contingencies
- Management expected continued solid growth in sales and profitability in 2018 and planned to ship 22 EUV systems, with shipments expected to be weighted toward the second half of the year. Q1 2018 guidance was sales of about €2.2 billion, gross margin of 47%–48%, R&D costs of about €350 million, SG&A costs of about €115 million and an annualized effective tax rate of about 14%.
- Long-term 2020 ambitions were an annual revenue opportunity of about €11 billion and EPS above €9. These are forward-looking targets, not assured results.
- Key execution risks include EUV availability, productivity and source-power milestones; consistency across tools and customer sites; scaling manufacturing and service capacity; supplier delivery and quality; and the technical and commercial success of High-NA and other R&D programs.
- ASML depends heavily on a small number of suppliers. Carl Zeiss SMT is its sole supplier of critical optical columns and represented 26.6% of system cost of sales in 2017. ASML had a remaining estimated High-NA funding commitment to Carl Zeiss of €925.5 million at year-end.
- Customer concentration is significant: the largest customer represented 27.4% of 2017 sales. The three largest customers accounted for 64.7% of accounts receivable and finance receivables at year-end.
- Nikon filed patent litigation against ASML in the Netherlands and Japan in 2017, and against Carl Zeiss SMT in Germany; ASML and Carl Zeiss also brought patent claims against Nikon. The company could not predict the outcome. Potential damages, injunctions or settlement costs could materially affect results or sales.
- Other material risks include semiconductor-industry cyclicality, competition, foreign-exchange exposure, cybersecurity and IT disruption, international and geopolitical exposure (including Taiwan and South Korea), tax-law changes, and the ability to attract and retain skilled employees.
- ASML proposed a €1.40-per-share dividend for 2017, subject to shareholder approval, and announced a 2018–2019 buyback program of up to €2.5 billion. Buybacks may be suspended or changed. The company also disclosed a €148.8 million liability for unrecognized tax benefits.
- U.S. tax reform was expected to have only a minor net tax effect, but assessment was ongoing. Adoption of the new revenue-recognition standard was expected to change timing; the precise impact was not yet reasonably estimable. The auditor reported effective internal control over financial reporting and issued an unqualified opinion on the financial statements.
Important facts for investors to verify
- Check subsequent results against the 2018 EUV shipment plan of 22 systems and the stated back-end-loaded shipment profile, including actual productivity, availability and gross-margin contribution.
- Review whether the sharp sales and receivables growth converted into cash; year-end receivables rose to €1,772.3 million from €700.2 million, while cash and cash equivalents fell.
- Track resolution and financial exposure from the Nikon litigation, including any injunctions, damages, settlements or effects on Carl Zeiss component supply.
- Assess progress on the High-NA program and the €925.5 million remaining Carl Zeiss funding commitment, alongside the strategic value and performance of the 24.9% investment.
- Verify delivery of the proposed dividend and buyback plan, and monitor net debt, liquidity and capital spending as growth investments continue.
- Review adoption effects of new revenue-recognition and lease-accounting standards, including any restated comparisons and resulting changes to revenue timing or balance-sheet presentation.